Abstract:BACKGROUND:Nearly 30% of clear cell renal cell carcinoma (ccRCC) patients present with metastasis at the time of diagnosis, and the prognosis for these patients is poor. Therefore, novel potential prognostic biomarkers and therapeutic targets for ccRCC could be helpful. Emerging evidence indicates that lncRNAs play important roles in cancer tumorigenesis and could be used as potential biomarkers or therapeutic targets. PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) is a relatively novel lncRNA that plays an important role in the development of multiple cancers. However, the clinical significance and molecular mechanism of PANDAR in ccRCC are still elusive. In the present study, we attempted to elucidate the role of PANDAR in ccRCC.METHODS:The relative expression level of lncRNA PANDAR was quantified by real-time qPCR in 62 paired ccRCC tissues and in renal cancer cell lines, and its association with overall survival was assessed by statistical analysis. The biological functions of lncRNA PANDAR on ccRCC cells were determined both in vitro and in vivo.RESULTS:PANDAR expression was significantly upregulated in tumor tissues and cell lines compared with normal counterparts. Moreover, PANDAR served as an independent predictor of overall survival, and increased PANDAR expression was positively correlated with an advanced TNM stage. Further experiments demonstrated that PANDAR silencing can significantly inhibit cell proliferation and invasion, induce cell cycle arrest in the G1 phase and significantly promote apoptosis in 7860 and Caki-1 cell lines. In addition, in vivo experiments confirmed that downregulation of PANDAR inhibited the tumorigenic ability of 7860 cells in nude mice. Silencing of PANDAR also inhibited the expression of Bcl-2 and Mcl-1 and upregulated the expression of Bax in vivo.CONCLUSIONS:Our results suggest that PANDAR is involved in ccRCC progression and may serve as a potential prognostic biomarker and therapeutic target.

Overexpression of Long Non-Coding RNA Differentiation Antagonizing Non-Protein Coding RNA Inhibits the Proliferation, Migration and Invasion and Promotes Apoptosis of Renal Cell Carcinoma.

Long Noncoding RNA DANCR in Various Cancers: a Meta-Analysis and Bioinformatics.

Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications

An Increase in Long Non-Coding RNA PANDAR is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma

Long Non-coding RNA DANCR As an Emerging Therapeutic Target in Human Cancers

Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

Long Non‑coding RNA DANCR Promotes Nasopharyngeal Carcinoma Cell Proliferation and Migration.

LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.

Long Noncoding RNA BX357664 Regulates Cell Proliferation and Epithelial-to-mesenchymal Transition Via Inhibition of TGF-β1/p38/HSP27 Signaling in Renal Cell Carcinoma

Long non‐coding RNA DANCR aggravates breast cancer through the miR‐34c/E2F1 feedback loop

LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.

Long Noncoding RNA DANCR Increases Stemness Features of Hepatocellular Carcinoma by Derepression of CTNNB1.

Long Noncoding RNA LINC01133 Promotes the Malignant Behaviors of Renal Cell Carcinoma by Regulating the miR-30b-5p/Rab3D Axis

DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer

Long Non-Coding RNA DANCR Promotes Malignant Phenotypes of Bladder Cancer Cells by Modulating the Mir-149/Msi2 Axis As a Cerna.

Long intergenic non-coding RNA 1939 inhibits proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154

Long Non-Coding RNA DANCR Promotes Cervical Cancer Growth Via Activation of the Wnt/β-catenin Signaling Pathway

Long Intergenic Non-Coding RNA 1939 Eliminates Proliferation and Migration of Human Renal Cell Carcinoma (RCC) Cells by Down-Regulation of Mir-154.

Lncrnas Expression Signatures Of Renal Clear Cell Carcinoma Revealed By Microarray

Highly Expressed Lncrna CRNDE Promotes Cell Proliferation Through Wnt/β-catenin Signaling in Renal Cell Carcinoma